Author | Owen O'Connor | OncLive

Author | Owen O'Connor


Dr. O'Connor on Recent FDA Approvals in MCL

November 15, 2017


Owen O'Connor, MD, PhD, professor of medicine and Experimental Therapeutics, director of the Center for Lymphoid Malignancies, Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, discusses the recent FDA approval of acalabrutinib (Calquence) for patients with mantle cell lymphoma (MCL).